Mucosamin Range

Targeted treatment for oral mucositis and dry mouth

Mucosamin treats and relieves the symptoms of oral mucositis (OM). OM is an acute inflammatory and ulcerative complication of the mucosal membrane that commonly occurs during cancer therapy. OM is one of the more significant side-effects of cancer treatment and can result from systemic chemotherapy, radiation therapy, or a combination of the two.

Mucosamin protects the healthy oral mucosa, whilst providing pain relief and promoting accelerated wound healing of painful lesions, following oral surgery.1,2 It has been formulated to help the process of regeneration of the oral mucosa, promote healing of areas of ulceration, and reduce local sensitivity within the mouth. Mucosamin forms a soothing layer to hydrate the oral mucosa and modulates osmotic balance to help relieve the symptoms of dry mouth.3

How will Mucosamin Mouthwash and Mucosamin Oral Spray help?

  • Protection of the healthy oral mucosa
  • Relief from dry mouth and pain
  • Healing of mouth ulcers and oral lesions

It is estimated that

97%

of patients who receive radiotherapy for head and neck cancer will develop some form of mucositis, which can include oral mucositis4

40%

of patients receiving chemotherapy will develop some degree of mucositis4

Mucosamin Mouthwash

Soothing mouthwash to help protect the oral mucosal layer

Mucosamin Mouthwash is a topical oral solution used to help in the treatment of oral mucositis, induced by cancer treatment. It has a protective action, helps to hydrate, provides pain relief, and promotes the repair of the oral mucosa. It can be used to help reduce the incidence of oral mucositis. It is recommended for use alongside the patients daily dental routine and can be used in combination with Mucosamin Oral Spray for convenient and effective relief.

Size
250ml bottle


How much to use
5-10ml of the Mucosamin Mouthwash

How to use
Keep in the mouth for 1 minute each time and avoid rinsing with water afterwards

How often to use
Three to four times a day

Legal category
CE Class IIa medical device

NHS List Price5
£19.00

RRP
£22.99

PIP Code
408-8464

Mucosamin Oral Spray

Convenient spray for fast, targeted relief when and where it’s needed

Mucosamin® is a fluid gel used to help in the treatment of oral mucositis induced by the cancer treatments, chemotherapy and radiotherapy. The spray formulation allows difficult areas of the mouth to be reached, for fast, targeted relief of pain caused by oral lesions and mucositis; whilst helping to support wound healing.1,2 Ideal for use as and when it’s needed and can be used in combination with Mucosamin® Mouthwash for effective relief.

Size
30ml bottle

How much to use
Apply a uniform layer by repeatedly spraying until the entire affected area is covered

How to use
Use the spray nozzle to treat specific areas in the mouth. Avoid rinsing with water after use

How often to use
3 or 4 times a day according to severity of symptoms

Legal category
CE Class IIa medical device

NHS List Price5
£19.00

RRP
£22.99

PIP Code
408-8480

Mucosamin Mouthwash and Mucosamin Oral Spray can be used together for convenient and effective relief


The mouthwash is recommended for use alongside daily dental routine, while the oral spray is useful for relief as it’s needed throughout the day.

Protects – Relieves – Heals

Recommend Mucosamin Mouthwash and Mucosamin Oral Spray to your patients for:

Protection of healthy oral mucosa

Relief from dry mouth

Relief from burning mouth syndrome

Healing of mouth ulcers

Healing following surgery in mouth

For those patients undergoing cancer treatment,
Mucosamin can be used to reduce the severity of oral mucositis symptoms.

References

Favia, G. et al. Accelerated wound healing of oral soft tissues and angiogenic effect induced by a pool of amino acids combined to sodium hyaluronate (Aminogam). J Biol Regul Homeost Agents. 2008: 22(2):109-116

Colella, G. et al. Amino acid-enriched sodium hyaluronate enhances keratinocyte scattering, chemotaxis and wound healing through ß1-dependent mechanisms. J of Stomatol Invest. 2009: 3: 21-29

Mariggio, M. et al. Enhancement of fi broblast proliferation, collagen biosynthesis and production of growth factors as a result of combining sodium hyaluronate and amino acids. Int J Immunopathol

https://www.mims.co.uk (accessed July 2024)

Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard

Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148.

MUC1010461L2_JUL2024